Recurrent hepatogastric fistula during lenvatinib therapy for advanced hepatocellular carcinoma managed by over-the-scope clip closure: a case report

Objective: Lenvatinib is an oral multitarget tyrosine kinase inhibitor (mTKI) and is recommended for patients with advanced hepatocellular carcinoma (HCC) with Child-Pugh A liver function, who are not amenable to surgical resection, locoregional treatment, or transcatheter arterial chemoembolization...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, Takao, Kochi, Takahiro, Watanabe, Keitaro, Hanai, Tatsunori, Imai, Kenji, Suetsugu, Atsushi, Takai, Koji, Shiraki, Makoto, Katsumura, Naoki, Shimizu, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Association of Rural Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016677/
https://www.ncbi.nlm.nih.gov/pubmed/33833836
http://dx.doi.org/10.2185/jrm.2020-044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016677/
https://www.ncbi.nlm.nih.gov/pubmed/33833836
http://dx.doi.org/10.2185/jrm.2020-044

Ejemplares similares